Best Telehealth Clinics in Minnesota (2026)

Minnesota's telehealth statute is codified at Minn. Stat. § 147.033 (Telemedicine Practice). The state permits telehealth prescribing of controlled substances but imposes a specific requirement for certain medications: an in-person referral from a Minnesota-licensed provider before a telehealth-only provider can prescribe testosterone or other controlled substances. This referral requirement is the key distinction that sets Minnesota apart from most states.

Under § 147.033, a provider practicing telemedicine must establish a physician-patient relationship. For controlled substance prescribing, the Board of Medical Practice interprets this to require either (1) an in-person evaluation by the prescribing provider, or (2) an in-person referral from another Minnesota-licensed provider. The referral pathway is the one most telehealth platforms use, but it adds a step that providers in most other states do not require.

This referral requirement is the likely reason Feel30 excludes Minnesota from its service area. Platforms that cannot coordinate an in-person referral network in Minnesota face operational challenges that make the state less attractive to serve.

Minnesota is an active IMLC member. The state enacted IMLC legislation, and out-of-state physicians can obtain expedited Minnesota licensure through the compact. However, IMLC licensure does not waive the in-person referral requirement for controlled substances.

Minn. Stat. § 62A.67 establishes telehealth coverage parity for commercial insurance. Minnesota Medicaid (Medical Assistance) covers telehealth services and has maintained coverage parity since COVID-era expansions were made permanent. MinnesotaCare (the state's Basic Health Program) also covers telehealth.

Minnesota Medicaid covers GLP-1 receptor agonists for both diabetes and obesity. Coverage for weight management was added through pharmacy benefit updates and requires prior authorization with documented BMI criteria. This makes Minnesota one of the more accessible states for Medicaid-covered weight loss medication.

The Minnesota Board of Pharmacy regulates prescription dispensing and requires compliance with the state PDMP (MN PMP) under Minn. Stat. § 152.126. PDMP checks are required before prescribing Schedule II through IV controlled substances.

Minnesota has 5.7 million residents. Provider availability is moderate. The in-person referral requirement for controlled substances under § 147.033 reduces the pool of telehealth TRT providers compared to states without this barrier. Feel30 explicitly excludes Minnesota, likely due to this requirement.

All-50-state providers serve Minnesota. Maximus ($100/mo), Hone Health ($25/mo), and Sesame Care are available. TRT Nation ($99/mo, 45 states) includes MN. BraverX ($129/mo), PeterMD ($99/mo), DudeMeds ($77/mo), and Titan Medical ($99/mo) list Minnesota. These platforms presumably have referral workflows or Minnesota-based providers to meet the § 147.033 requirement.

GLP-1 availability is unrestricted since GLP-1s are not controlled substances and the referral requirement does not apply. Embody, SkinnyRx, DirectMeds, Zealthy, Remedy Meds, GobyMeds, Sesame Care, MEDVi, Shed, Sunlight, and Mochi Health serve Minnesota. Medicaid coverage for GLP-1s adds another access pathway.

All HRT, hair loss, and ED providers serve Minnesota. Midi Health accepts insurance. No known HRT, hair loss, or ED provider exclusions for MN.

Enhance MD's 11-state exclusion list may include Minnesota due to the referral requirement. Verify directly with any provider before starting treatment.

TRT pricing from available providers: DudeMeds $77/mo ($1,124/year), TRT Nation $99/mo ($1,446/year), PeterMD $99/mo ($1,188/year), Maximus $100/mo ($1,300/year), BraverX $129/mo ($1,548/year), Defy Medical $200/mo ($2,800/year).

GLP-1 ranges from $99/mo to $399/mo. Median is $179/mo. Minnesota Medical Assistance covers GLP-1s for obesity with prior authorization. Patients on Medical Assistance should check coverage criteria before paying out of pocket. MinnesotaCare may also cover GLP-1s — verify with the plan.

Minnesota does not tax prescription medications. The state sales tax is 6.875% (plus local taxes) but Rx drugs are exempt. Minnesota has a progressive income tax with rates from 5.35% to 9.85%, one of the higher state income tax rates nationally.

HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo), Alloy ($49/mo). ED: Hims $17/mo to MEDVi $119/mo.

The in-person referral requirement may add cost for TRT patients who need to see a local provider before starting telehealth testosterone therapy. This is an indirect cost not reflected in the monthly subscription prices.

TRT (testosterone replacement therapy)

Minnesota requires an in-person referral from a Minnesota-licensed provider before telehealth-only TRT prescribing under § 147.033. The federal DEA waiver through December 2026 provides the federal basis for telehealth Schedule III prescribing, but it does not override the state referral requirement. PDMP check required. Both compounded and FDA-approved testosterone are available. Feel30 excludes MN, likely due to this requirement.

GLP-1 weight loss

No state-specific GLP-1 restrictions in Minnesota. The referral requirement does not apply to non-controlled substances. Federal FDA compounding rules apply. Minnesota Medical Assistance covers GLP-1s for obesity with prior authorization.

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in Minnesota. Non-controlled HRT medications are not subject to the referral requirement. No additional state restrictions apply.

Hair loss

Hair loss treatment follows standard federal prescribing rules in Minnesota. No additional state restrictions apply.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in Minnesota. No additional state restrictions apply.

Peptides

Peptide therapy follows standard federal rules in Minnesota. Controlled peptides would be subject to the § 147.033 referral requirement. Non-controlled peptides like BPC-157 and sermorelin are not affected.